Association of Hospital Procedural Volume With Outcomes of Percutaneous Left Atrial Appendage Occlusion

被引:22
作者
Nazir, Salik [1 ]
Ahuja, Keerat Rai [2 ]
Kolte, Dhaval [3 ,4 ]
Isogai, Toshiaki [5 ]
Michihata, Nobuaki [6 ]
Saad, Anas M. [5 ]
Ramanathan, P. Kasi [7 ]
Krishnaswamy, Amar [5 ]
Wazni, Oussama M. [5 ]
Saliba, Walid I. [5 ]
Gupta, Rajesh [1 ]
Kapadia, Samir R. [5 ]
机构
[1] Univ Toledo, Med Ctr, Div Cardiol, 2801 W Bancroft St, Toledo, OH 43606 USA
[2] Reading Hosp, Tower Hlth Syst, Div Cardiol, W Reading, PA USA
[3] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
[4] Harvard Med Sch, Boston, MA 02115 USA
[5] Cleveland Clin, Inst Heart & Vasc, Div Cardiol, Cleveland, OH 44106 USA
[6] Univ Tokyo, Dept Hlth Serv Res, Tokyo, Japan
[7] Promed Toledo Hosp, Toledo, OH USA
关键词
hospital volume; left atrial appendage occlusion; outcomes; Watchman; CLOSURE; FIBRILLATION; WARFARIN; MORTALITY;
D O I
10.1016/j.jcin.2020.11.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to examine the association between percutaneous left atrial appendage occlusion (LAAO) procedural volume and in-hospital outcomes. BACKGROUND Several studies have demonstrated an inverse volume-outcome relationship for patients undergoing invasive cardiac procedures. Whether a similar association exists for percutaneous LAAO remains unknown. METHODS Patients undergoing LAAO in 2017 were identified in the Nationwide Readmissions Database. Hospitals were categorized into 3 groups on the basis of tertiles of annual procedural volume: low (5 to 15 cases/year), medium (17 to 31 cases/year), and high (32 to 211 cases/year). Multivariate hierarchical logistic regression and restricted cubic spline analyses were performed to examine the association of hospital LAAO volume and outcomes. The primary outcome was in-hospital major adverse events (MAE), defined as a composite of mortality, stroke or transient ischemic attack, bleeding or transfusion, vascular complications, myocardial infarction, systemic embolization, and pericardial effusion or tamponade requiring pericardiocentesis or surgery. RESULTS This study included 5,949 LAAO procedures performed across 196 hospitals with a median annual procedural volume of 41 (interquartile range: 25 to 67). Low-volume hospitals had higher rates of in-hospital MAE (9.5% vs. 5.6%; p < 0.001), stroke or transient ischemic attack (2.1% vs. 1.3%; p = 0.049), and bleeding or transfusion (6.1% vs. 3.5%; p = 0.002) compared with high-volume hospitals. No differences were noted for other components of MAE and index length of stay. On multivariate analysis, higher procedural volume was associated with lower rates of in-hospital MAE, with an adjusted odds ratio for medium versus low volume of 0.69 (95% confidence interval: 0.46 to 1.04; p = 0.08) and for high versus low volume of 0.55 (95% confidence interval: 0.37 to 0.82; p = 0.003). CONCLUSIONS Higher hospital procedural volume is associated with better outcomes for LAAO procedures. Further studies are needed to determine if this relationship persists for long-term outcomes. (J Am Coll Cardiol Intv 2021;14:554-61) (c) 2021 by the American College of Cardiology Foundation.
引用
收藏
页码:554 / 561
页数:8
相关论文
共 18 条
  • [1] Agency for Healthcare Research and Quality, OVERVIEW NATIONWIDE
  • [2] Procedural Volume and Outcomes After Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease-Report From the National Clinical Data (J-PCI Registry)
    Aikawa, Tadao
    Yamaji, Kyohei
    Nagai, Toshiyuki
    Kohsaka, Shun
    Kamiya, Kiwamu
    Omote, Kazunori
    Inohara, Taku
    Numasawa, Yohei
    Tsujita, Kenichi
    Amano, Tetsuya
    Ikari, Yuji
    Anzai, Toshihisa
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (09):
  • [3] [Anonymous], NAT COV DET NCD TRAN
  • [4] Volume-Outcome Association of Mitral Valve Surgery in the United States
    Badhwar, Vinay
    Vemulapalli, Sreekanth
    Mack, Michael A.
    Gillinov, A. Marc
    Chikwe, Joanna
    Dearani, Joseph A.
    Grau-Sepulveda, Maria, V
    Habib, Robert
    Rankin, J. Scott
    Jacobs, Jeffrey P.
    McCarthy, Patrick M.
    Bloom, Jordan P.
    Kurlansky, Paul A.
    von Ballmoos, Moritz C. Wyler
    Thourani, Vinod H.
    Edgerton, James R.
    Vassileva, Christina M.
    Gammie, James S.
    Shahian, David M.
    [J]. JAMA CARDIOLOGY, 2020, 5 (10) : 1092 - 1101
  • [5] Hospital volume and surgical mortality in the United States.
    Birkmeyer, JD
    Siewers, AE
    Finlayson, EVA
    Stukel, TA
    Lucas, FL
    Batista, I
    Welch, HG
    Wennberg, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) : 1128 - 1137
  • [6] Centers for Medicare and Medicaid Services, NAT COV AN NCA TRANS
  • [7] Operator Experience and Outcomes of Transcatheter Mitral Valve Repair in the United States
    Chhatriwalla, Adnan K.
    Vemulapalli, Sreekanth
    Szerlip, Molly
    Kodali, Susheel
    Hahn, Rebecca T.
    Saxon, John T.
    Mack, Michael J.
    Ailawadi, Gorav
    Rymer, Jennifer
    Manandhar, Pratik
    Kosinski, Andrzej S.
    Sorajja, Paul
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (24) : 2955 - 2965
  • [8] The NCDR Left Atrial Appendage Occlusion Registry
    Freeman, James, V
    Varosy, Paul
    Price, Matthew J.
    Slotwiner, David
    Kusumoto, Fred M.
    Rammohan, Chidambaram
    Kavinsky, Clifford J.
    Turi, Zoltan G.
    Akar, Joseph
    Koutras, Cristina
    Curtis, Jeptha P.
    Masoudi, Frederick A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (13) : 1503 - 1518
  • [9] Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
    Holmes, David R.
    Reddy, Vivek Y.
    Turi, Zoltan G.
    Doshi, Shephal K.
    Sievert, Horst
    Buchbinder, Maurice
    Mullin, Christopher M.
    Sick, Peter
    [J]. LANCET, 2009, 374 (9689) : 534 - 542
  • [10] Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy
    Holmes, David R., Jr.
    Kar, Saibal
    Price, Matthew J.
    Whisenant, Brian
    Sievert, Horst
    Doshi, Shephal K.
    Huber, Kenneth
    Reddy, Vivek Y.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (01) : 1 - 12